產(chǎn)品中心
一(yī)抗(kàng)
英文名(míng)稱 Anti-Bcr
濃 度(dù) 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆(lóng)類(lèi)型(xíng) polyclonal
交(jiāo)叉(chā)反(fǎn)應(yīng) Human, Mouse, Rat, Chicken, Dog, Cow, Horse, Rabbit
產品類型 一(yī)抗
研(yán)究領(lǐng)域(yù) 免(miǎn)疫(yì)學(xué) 細胞(bāo)膜(mó)受體
蛋(dàn)白分子(zǐ)量(liáng) predicted molecular weight: 143kDa
性 狀 Lyophilized or Liquid
免 疫(yì) 原(yuán) KLH conjugated synthetic peptide derived from human Bcr (1225-1271aa)
亞(yà) 型 IgG
純化方法(fǎ) affinity purified by Protein A
儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
產品應用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產品介(jiè)紹 The breakpoint cluster region protein (Bcr) is best know to be involved in genomic translocation with fusion partner Abl (Cbr-Abl) causing chronic myelogenous leukemia (CML). This 160 kDa protein contains a serine/threonine kinase domain, an SH2 binding domain, a GTP/GDP exchange domain and a C-term domain which functions as a GTPase activating protein for p21rac and CDC42. Additionally, Bcr is involved in signal transduction and can down regulate Ras mediated cell signaling.
Function : GTPase-activating protein for RAC1 and CDC42. Promotes the exchange of RAC or CDC42-bound GDP by GTP, thereby activating them. Displays serine/threonine kinase activity.
Subunit : Homotetramer. Interacts with PDZK1. May interact with CCPG1. Interacts with FES/FPS, ABL1, PIK3R1 and GRB2. Interacts with HCK.
Subcellular Location : Cytoplasm.
Post-translational modifications : Autophosphorylated. Phosphorylated by FES/FPS on tyrosine residues, leading to down-regulation of the BCR kinase activity. Phosphorylation at Tyr-177 by HCK is important for interaction with GRB2.
DISEASE : Note=A chromosomal aberration involving BCR is a cause of chronic myeloid leukemia. Translocation t(9;22)(q34;q11) with ABL1. The translocation produces a BCR-ABL found also in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
Similarity : Contains 1 C2 domain.
Contains 1 DH (DBL-homology) domain.
Contains 1 PH domain.
Contains 1 Rho-GAP domain.
Database links : UniProtKB/Swiss-Prot: P11274.2
中文名稱(chēng)： Bcr抗(kàng)體
別(bié) 名(míng) ALL; BCR 1; BCR/ABL FUSION GENE INCLUDED; BCR/FGFR1 FUSION GENE INCLUDED; BCR/PDGFRA FUSION GENE INCLUDED; BCR1; breakpoint cluster region; CML; PHL; BCR_HUMAN.詳細介(jiè)紹：
濃 度(dù) 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來源 Rabbit
克隆(lóng)類(lèi)型(xíng) polyclonal
交(jiāo)叉(chā)反(fǎn)應(yīng) Human, Mouse, Rat, Chicken, Dog, Cow, Horse, Rabbit
產品類型 一(yī)抗
研(yán)究領(lǐng)域(yù) 免(miǎn)疫(yì)學(xué) 細胞(bāo)膜(mó)受體
蛋(dàn)白分子(zǐ)量(liáng) predicted molecular weight: 143kDa
性 狀 Lyophilized or Liquid
免 疫(yì) 原(yuán) KLH conjugated synthetic peptide derived from human Bcr (1225-1271aa)
亞(yà) 型 IgG
純化方法(fǎ) affinity purified by Protein A
儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
產品應用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
相(xiāng)關(guān)資(zī)料(liào)：
產品介(jiè)紹 The breakpoint cluster region protein (Bcr) is best know to be involved in genomic translocation with fusion partner Abl (Cbr-Abl) causing chronic myelogenous leukemia (CML). This 160 kDa protein contains a serine/threonine kinase domain, an SH2 binding domain, a GTP/GDP exchange domain and a C-term domain which functions as a GTPase activating protein for p21rac and CDC42. Additionally, Bcr is involved in signal transduction and can down regulate Ras mediated cell signaling.
Function : GTPase-activating protein for RAC1 and CDC42. Promotes the exchange of RAC or CDC42-bound GDP by GTP, thereby activating them. Displays serine/threonine kinase activity.
Subunit : Homotetramer. Interacts with PDZK1. May interact with CCPG1. Interacts with FES/FPS, ABL1, PIK3R1 and GRB2. Interacts with HCK.
Subcellular Location : Cytoplasm.
Post-translational modifications : Autophosphorylated. Phosphorylated by FES/FPS on tyrosine residues, leading to down-regulation of the BCR kinase activity. Phosphorylation at Tyr-177 by HCK is important for interaction with GRB2.
DISEASE : Note=A chromosomal aberration involving BCR is a cause of chronic myeloid leukemia. Translocation t(9;22)(q34;q11) with ABL1. The translocation produces a BCR-ABL found also in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
Similarity : Contains 1 C2 domain.
Contains 1 DH (DBL-homology) domain.
Contains 1 PH domain.
Contains 1 Rho-GAP domain.
Database links : UniProtKB/Swiss-Prot: P11274.2
